Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0KU6D
|
||||
Former ID |
DNC011046
|
||||
Drug Name |
(R,S)-1-(6-fluoro-1H-indol-1-yl)propan-2-amine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551219] | ||
Structure |
Download2D MOL |
||||
Formula |
C11H13FN2
|
||||
Canonical SMILES |
CC(CN1C=CC2=C1C=C(C=C2)F)N
|
||||
InChI |
1S/C11H13FN2/c1-8(13)7-14-5-4-9-2-3-10(12)6-11(9)14/h2-6,8H,7,13H2,1H3
|
||||
InChIKey |
WZMZEXSQEAPONX-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [551219] | |
5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [551219] | ||
WikiPathways | Serotonin Receptor 2 and STAT3 Signaling | ||||
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
SIDS Susceptibility Pathways | |||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.